KCNAB2

KCNAB2 encodes Kvβ2, an auxiliary beta subunit of Kv1 (Shaker-family) voltage-gated potassium channels that belongs to the aldo-keto reductase superfamily yet regulates neuronal excitability through mechanisms independent of its catalytic activity (PMID:8001150, PMID:11825900). Kvβ2 binds the T1 tetramerization domain of all Kv1 alpha subunits, forming obligate complexes (notably Kv1.1/Kv1.2/Kvβ2) that are essential for correct axonal targeting and surface expression of the channel, and it modulates inactivation gating to shape action potential repolarization and afterhyperpolarization in amygdala projection neurons and midbrain dopamine neurons (PMID:8636142, PMID:12893943, PMID:21209188, PMID:35788155). The Kvβ2 subunit is scaffolded to PKCζ via ZIP adaptor proteins, linking channel regulation to neurotrophic signaling (PMID:10477520). Hemizygous deletion of KCNAB2 in human 1p36 deletion syndrome is associated with epilepsy and infantile spasms, consistent with its role in membrane repolarization (PMID:11580756).

1. 1994 High

   Establishing the structural identity of Kvβ2 as an aldo-keto reductase superfamily member provided the first framework for understanding how an ion channel accessory subunit could possess enzymatic architecture, raising the question of whether catalytic activity contributes to channel regulation.

   Evidence Sequence and structural homology analysis of Kvβ2 core domain

   PMID:8001150

   Open questions at the time

   • No demonstration that AKR catalytic activity is functionally relevant to channel regulation
   • Physiological substrate for the AKR domain unknown
2. 1995 High

   Demonstrating that Kvβ2 directly modulates Kv1.4 inactivation kinetics in heterologous expression established it as a functional electrophysiological regulator, not merely a structural accessory.

   Evidence Heterologous co-expression of Kvβ2 with Kv1.4, two-electrode voltage clamp electrophysiology

   PMID:7649300

   Open questions at the time

   • Mechanism of inactivation modulation not defined at molecular level
   • Native channel context not tested
3. 1996 High

   Mapping the selectivity of Kvβ2 for all Kv1 alpha subunits and showing that the conserved core (not the N-terminus) mediates association defined the molecular rules governing alpha/beta complex assembly.

   Evidence Co-immunoprecipitation of Kvβ2 with multiple Kv subfamilies in transfected mammalian cells

   PMID:8636142

   Open questions at the time

   • Stoichiometry of the alpha-beta complex not resolved
   • Whether the N-terminal domain has independent functions unclear
4. 1999 High

   Identification of region-specific Kv1.1/Kv1.2/Kvβ2 complexes in human brain and their localization with Caspr2 at juxtaparanodal regions established the native channel composition and subcellular context in myelinated axons.

   Evidence Sequential immunoprecipitation from human brain autopsy tissue; co-IP and immunofluorescence in myelinated axons

   PMID:10428084 PMID:10624965

   Open questions at the time

   • Functional consequence of juxtaparanodal localization for Kvβ2 specifically not tested
   • Whether Caspr2 interaction is direct or bridged through Kv1 alpha subunits not resolved
5. 1999 High

   Discovery that ZIP scaffold proteins physically link Kvβ2 to PKCζ, forming a ternary signaling complex regulated by neurotrophic factors, revealed a mechanism for dynamic post-translational regulation of the channel complex.

   Evidence Co-immunoprecipitation, in vitro phosphorylation assays, and yeast two-hybrid screening

   PMID:10477520

   Open questions at the time

   • Phosphorylation sites on Kvβ2 not mapped
   • Functional electrophysiological consequence of PKCζ-mediated phosphorylation not shown
6. 2001 Medium

   Clinical association of KCNAB2 hemizygous deletion with epilepsy in 1p36 deletion syndrome patients provided the first direct human genetic evidence that Kvβ2 loss compromises seizure threshold.

   Evidence FISH genotyping of 24 1p36 deletion patients correlated with EEG and clinical seizure phenotype

   PMID:11580756

   Open questions at the time

   • Contiguous gene deletion confounds attribution to KCNAB2 alone
   • No rescue or single-gene validation
   • Mechanism linking haploinsufficiency to seizures not demonstrated
7. 2002 High

   Kcnab2-null mice displayed seizures and reduced lifespan yet retained normal Kv1 localization and glycosylation, while a catalytically dead Y90F knock-in showed no overt phenotype — dissociating Kvβ2's excitability role from both chaperone and AKR enzymatic functions.

   Evidence Constitutive knockout and Y90F knock-in mice with immunohistochemistry, glycosylation analysis, and behavioral phenotyping

   PMID:11825900

   Open questions at the time

   • The mechanism by which Kvβ2 regulates excitability if not via chaperone or AKR activity remains unresolved
   • Subtle gating phenotypes in Y90F mice not comprehensively characterized
8. 2003 High

   Showing that mutations in the Kv1 T1 domain that abolish Kvβ association also abolish axonal targeting established that Kvβ2 binding to T1 is essential for correct polarized trafficking of Kv1 channels in neurons.

   Evidence Chimeric CD4-T1 fusion constructs and T1 mutagenesis with surface expression assays in cultured neurons

   PMID:12893943

   Open questions at the time

   • Adaptor or motor proteins linking the Kvβ2-T1 complex to axonal transport machinery not identified
   • Whether Kvβ2 versus other Kvβ isoforms are differentially required not tested
9. 2011 High

   Kcnab2 knockout mice exhibited associative learning deficits and increased excitability in lateral amygdala projection neurons — specifically a reduced slow afterhyperpolarization — linking Kvβ2 to circuit-level function in fear memory.

   Evidence Constitutive Kcnab2 KO mice, fear conditioning, whole-cell patch-clamp in acute brain slices

   PMID:21209188

   Open questions at the time

   • Contribution of specific Kv1 alpha subunit partners in amygdala not dissected
   • Whether learning deficit is developmental or acute not resolved
10. 2022 High

    Cell-type-specific CRISPR mutagenesis of Kcnab2 in dopamine neurons recapitulated Kv1.2 loss-of-function phenotypes — reduced surface Kv1.2, hyperpolarized inactivation shift, broadened action potentials, and increased spike irregularity — directly demonstrating that Kvβ2 controls Kv1.2 surface expression and gating in a defined neuronal population.

    Evidence Viral CRISPR/Cas9 in adult mouse dopamine neurons, surface biotinylation, whole-cell patch-clamp in acute slices

    PMID:35788155

    Open questions at the time

    • Molecular mechanism by which Kvβ2 loss reduces Kv1.2 surface expression not defined
    • Long-term behavioral consequences of dopamine neuron-specific loss not assessed
11. 2023 Medium

    Gain- and loss-of-function experiments in NSCLC cells revealed an unexpected tumor-suppressive role for KCNAB2 through inhibition of AKT-mTOR signaling, extending its functional significance beyond excitable cells.

    Evidence Stable overexpression and CRISPR KO in NSCLC lines, phosphoprotein arrays, Western blotting, xenograft model

    PMID:37852974

    Open questions at the time

    • Mechanism linking a potassium channel beta subunit to AKT-mTOR not elucidated
    • Whether the effect requires Kv1 alpha subunit interaction is untested
    • Single-laboratory finding not independently replicated
12. 2025 Medium

    FTO-mediated m6A methylation was identified as a post-transcriptional mechanism suppressing KCNAB2 expression in NSCLC, with FTO knockdown restoring KCNAB2 and inhibiting PI3K/AKT signaling, adding an epitranscriptomic regulatory layer.

    Evidence MeRIP-qPCR, FTO knockdown, KCNAB2 rescue, functional assays, xenograft model

    PMID:40114527

    Open questions at the time

    • Specific m6A sites on KCNAB2 mRNA not mapped at nucleotide resolution
    • Relevance of this regulation outside NSCLC unknown
    • Single-laboratory finding

• The molecular mechanism by which Kvβ2 regulates Kv1 channel surface expression and gating — given that it is neither an obligate chaperone nor dependent on AKR catalytic activity — remains the central unresolved question.
• No structural basis for how Kvβ2 promotes axonal targeting beyond T1 binding
• Physiological substrate or product of the AKR domain unknown
• PKCζ phosphorylation sites and their functional consequences on channel gating not defined